Deciphera Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Deciphera Pharmaceuticals

01/11/2023 13:31

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of 58 cents​​ per share for the quarter ended in
September, lower than the same quarter last year, when the
company reported EPS of -55 cents.  The mean expectation of
ten analysts for the quarter was for a loss of 61 cents per
share. Wall Street expected results to range from -68 cents
to -56 cents per share.
    * Revenue rose 20.4% to $43.31 million from a year ago;
analysts
expected $39.40 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 58 cents​.
    * The company reported a quarterly loss of $49.58 million.
    * Deciphera Pharmaceuticals Inc shares had fallen by 5.7%
this
quarter and lost 26.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $23.00 
This summary was machine generated from LSEG data November 1 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.61          -0.58          Beat
 Jun. 30 2023      -0.62          -0.57          Beat
 Mar. 31 2023      -0.59          -0.60          Missed
 Dec. 31 2022      -0.56          -0.60          Missed